Comparison of 3% and 7.5% Hypertonic Saline in Resuscitation After Traumatic Hypovolemic Shock

Hypertonic saline solutions (HSSs) (7.5%) are useful in the resuscitation of patients with hypovolemic shock because they provide immediate intravascular volume expansion via the delivery of a small volume of fluid, improving cardiac function. However, the effects of using 3% HSS in hypovolemic shoc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Shock (Augusta, Ga.) Ga.), 2015-03, Vol.43 (3), p.244-249
Hauptverfasser: Han, Juan, Ren, Hui-Qin, Zhao, Qing-Bo, Wu, You-Liang, Qiao, Zhuo-Yi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 249
container_issue 3
container_start_page 244
container_title Shock (Augusta, Ga.)
container_volume 43
creator Han, Juan
Ren, Hui-Qin
Zhao, Qing-Bo
Wu, You-Liang
Qiao, Zhuo-Yi
description Hypertonic saline solutions (HSSs) (7.5%) are useful in the resuscitation of patients with hypovolemic shock because they provide immediate intravascular volume expansion via the delivery of a small volume of fluid, improving cardiac function. However, the effects of using 3% HSS in hypovolemic shock resuscitation are not well known. This study was designed to compare the effects of and complications associated with 3% HSS, 7.5% HSS, and standard fluid in resuscitation. In total, 294 severe trauma patients were enrolled from December 2008 to February 2012 and subjected to a double-blind randomized clinical trial. Individual patients were treated with 3% HSS (250 mL), 7.5% HSS (250 mL), or lactated Ringer's solution (LRS) (250 mL). Mean arterial pressure, blood pressure, and heart rate were monitored and recorded before fluid infusion and at 10, 30, 45, and 60 min after infusion, and the incidence of complications and survival rate were analyzed. The results indicate that 3% and 7.5% HSSs rapidly restored mean arterial pressure and led to the requirement of an approximately 50% lower total fluid volume compared with the LRS group (P < 0.001). However, a single bolus of 7.5% HSS resulted in an increase in heart rate (mean of 127 beats/min) at 10 min after the start of resuscitation. Higher rates of arrhythmia and hypernatremia were noted in the 7.5% HSS group, whereas higher risks of renal failure (P< 0.001), coagulopathy (P < 0.001), and pulmonary edema (P < 0.001) were observed in the LRS group. Neither severe electrolyte disturbance nor anaphylaxis was observed in the HSS groups. It is notable that 3% HSS had similar effects on resuscitation because both the 7.5% HSS and LRS groups but resulted in a lower occurrence of complications. This study demonstrates the efficacy and safety of 3% HSS in the resuscitation of patients with hypovolemic shock.
doi_str_mv 10.1097/SHK.0000000000000303
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1690209851</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1690209851</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-9280762e74085d75e66443dffe5cfb1c0ea6d2da34a16febbaeb3647eb4030483</originalsourceid><addsrcrecordid>eNpdkEtLw0AQgBdRbK3-A5G9FLykzj7yOpaiViwItl4Nm80sRpNs3E2E_ntTWkWcywzDfDPMR8glgxmDNL5ZLx9n8DcEiCMyZqGEAEImj4caYhFwwfmInHn_DsClSONTMuIRpAy4GJPXha1b5UpvG2oNFVOqmoLGs3BKl9sWXWebUtO1qsoGadnQZ_S912WnunIg5qZDRzdO9fXQ0DvEftkK6x3zZvXHOTkxqvJ4ccgT8nJ3u1ksg9XT_cNivgq0CEUXpDyBOOIYS0jCIg4xiqQUhTEYapMzDaiighdKSMUig3muMBeRjDGXw9syERNyvd_bOvvZo--yuvQaq0o1aHufsSgFDmkSsmFU7ke1s947NFnrylq5bcYg25nNBrPZf7MDdnW40Oc1Fr_Qj0rxDccqctQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1690209851</pqid></control><display><type>article</type><title>Comparison of 3% and 7.5% Hypertonic Saline in Resuscitation After Traumatic Hypovolemic Shock</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Han, Juan ; Ren, Hui-Qin ; Zhao, Qing-Bo ; Wu, You-Liang ; Qiao, Zhuo-Yi</creator><creatorcontrib>Han, Juan ; Ren, Hui-Qin ; Zhao, Qing-Bo ; Wu, You-Liang ; Qiao, Zhuo-Yi</creatorcontrib><description>Hypertonic saline solutions (HSSs) (7.5%) are useful in the resuscitation of patients with hypovolemic shock because they provide immediate intravascular volume expansion via the delivery of a small volume of fluid, improving cardiac function. However, the effects of using 3% HSS in hypovolemic shock resuscitation are not well known. This study was designed to compare the effects of and complications associated with 3% HSS, 7.5% HSS, and standard fluid in resuscitation. In total, 294 severe trauma patients were enrolled from December 2008 to February 2012 and subjected to a double-blind randomized clinical trial. Individual patients were treated with 3% HSS (250 mL), 7.5% HSS (250 mL), or lactated Ringer's solution (LRS) (250 mL). Mean arterial pressure, blood pressure, and heart rate were monitored and recorded before fluid infusion and at 10, 30, 45, and 60 min after infusion, and the incidence of complications and survival rate were analyzed. The results indicate that 3% and 7.5% HSSs rapidly restored mean arterial pressure and led to the requirement of an approximately 50% lower total fluid volume compared with the LRS group (P &lt; 0.001). However, a single bolus of 7.5% HSS resulted in an increase in heart rate (mean of 127 beats/min) at 10 min after the start of resuscitation. Higher rates of arrhythmia and hypernatremia were noted in the 7.5% HSS group, whereas higher risks of renal failure (P&lt; 0.001), coagulopathy (P &lt; 0.001), and pulmonary edema (P &lt; 0.001) were observed in the LRS group. Neither severe electrolyte disturbance nor anaphylaxis was observed in the HSS groups. It is notable that 3% HSS had similar effects on resuscitation because both the 7.5% HSS and LRS groups but resulted in a lower occurrence of complications. This study demonstrates the efficacy and safety of 3% HSS in the resuscitation of patients with hypovolemic shock.</description><identifier>ISSN: 1073-2322</identifier><identifier>EISSN: 1540-0514</identifier><identifier>DOI: 10.1097/SHK.0000000000000303</identifier><identifier>PMID: 26091023</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Blood Pressure ; Double-Blind Method ; Female ; Fluid Therapy - adverse effects ; Fluid Therapy - methods ; Heart Rate ; Humans ; Hypovolemia - etiology ; Hypovolemia - physiopathology ; Hypovolemia - therapy ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Resuscitation - adverse effects ; Resuscitation - methods ; Saline Solution, Hypertonic - adverse effects ; Saline Solution, Hypertonic - chemistry ; Saline Solution, Hypertonic - therapeutic use ; Shock, Traumatic - complications ; Shock, Traumatic - physiopathology ; Shock, Traumatic - therapy ; Tachycardia, Sinus - etiology</subject><ispartof>Shock (Augusta, Ga.), 2015-03, Vol.43 (3), p.244-249</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-9280762e74085d75e66443dffe5cfb1c0ea6d2da34a16febbaeb3647eb4030483</citedby><cites>FETCH-LOGICAL-c353t-9280762e74085d75e66443dffe5cfb1c0ea6d2da34a16febbaeb3647eb4030483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26091023$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Han, Juan</creatorcontrib><creatorcontrib>Ren, Hui-Qin</creatorcontrib><creatorcontrib>Zhao, Qing-Bo</creatorcontrib><creatorcontrib>Wu, You-Liang</creatorcontrib><creatorcontrib>Qiao, Zhuo-Yi</creatorcontrib><title>Comparison of 3% and 7.5% Hypertonic Saline in Resuscitation After Traumatic Hypovolemic Shock</title><title>Shock (Augusta, Ga.)</title><addtitle>Shock</addtitle><description>Hypertonic saline solutions (HSSs) (7.5%) are useful in the resuscitation of patients with hypovolemic shock because they provide immediate intravascular volume expansion via the delivery of a small volume of fluid, improving cardiac function. However, the effects of using 3% HSS in hypovolemic shock resuscitation are not well known. This study was designed to compare the effects of and complications associated with 3% HSS, 7.5% HSS, and standard fluid in resuscitation. In total, 294 severe trauma patients were enrolled from December 2008 to February 2012 and subjected to a double-blind randomized clinical trial. Individual patients were treated with 3% HSS (250 mL), 7.5% HSS (250 mL), or lactated Ringer's solution (LRS) (250 mL). Mean arterial pressure, blood pressure, and heart rate were monitored and recorded before fluid infusion and at 10, 30, 45, and 60 min after infusion, and the incidence of complications and survival rate were analyzed. The results indicate that 3% and 7.5% HSSs rapidly restored mean arterial pressure and led to the requirement of an approximately 50% lower total fluid volume compared with the LRS group (P &lt; 0.001). However, a single bolus of 7.5% HSS resulted in an increase in heart rate (mean of 127 beats/min) at 10 min after the start of resuscitation. Higher rates of arrhythmia and hypernatremia were noted in the 7.5% HSS group, whereas higher risks of renal failure (P&lt; 0.001), coagulopathy (P &lt; 0.001), and pulmonary edema (P &lt; 0.001) were observed in the LRS group. Neither severe electrolyte disturbance nor anaphylaxis was observed in the HSS groups. It is notable that 3% HSS had similar effects on resuscitation because both the 7.5% HSS and LRS groups but resulted in a lower occurrence of complications. This study demonstrates the efficacy and safety of 3% HSS in the resuscitation of patients with hypovolemic shock.</description><subject>Adult</subject><subject>Blood Pressure</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Fluid Therapy - adverse effects</subject><subject>Fluid Therapy - methods</subject><subject>Heart Rate</subject><subject>Humans</subject><subject>Hypovolemia - etiology</subject><subject>Hypovolemia - physiopathology</subject><subject>Hypovolemia - therapy</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Resuscitation - adverse effects</subject><subject>Resuscitation - methods</subject><subject>Saline Solution, Hypertonic - adverse effects</subject><subject>Saline Solution, Hypertonic - chemistry</subject><subject>Saline Solution, Hypertonic - therapeutic use</subject><subject>Shock, Traumatic - complications</subject><subject>Shock, Traumatic - physiopathology</subject><subject>Shock, Traumatic - therapy</subject><subject>Tachycardia, Sinus - etiology</subject><issn>1073-2322</issn><issn>1540-0514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkEtLw0AQgBdRbK3-A5G9FLykzj7yOpaiViwItl4Nm80sRpNs3E2E_ntTWkWcywzDfDPMR8glgxmDNL5ZLx9n8DcEiCMyZqGEAEImj4caYhFwwfmInHn_DsClSONTMuIRpAy4GJPXha1b5UpvG2oNFVOqmoLGs3BKl9sWXWebUtO1qsoGadnQZ_S912WnunIg5qZDRzdO9fXQ0DvEftkK6x3zZvXHOTkxqvJ4ccgT8nJ3u1ksg9XT_cNivgq0CEUXpDyBOOIYS0jCIg4xiqQUhTEYapMzDaiighdKSMUig3muMBeRjDGXw9syERNyvd_bOvvZo--yuvQaq0o1aHufsSgFDmkSsmFU7ke1s947NFnrylq5bcYg25nNBrPZf7MDdnW40Oc1Fr_Qj0rxDccqctQ</recordid><startdate>201503</startdate><enddate>201503</enddate><creator>Han, Juan</creator><creator>Ren, Hui-Qin</creator><creator>Zhao, Qing-Bo</creator><creator>Wu, You-Liang</creator><creator>Qiao, Zhuo-Yi</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201503</creationdate><title>Comparison of 3% and 7.5% Hypertonic Saline in Resuscitation After Traumatic Hypovolemic Shock</title><author>Han, Juan ; Ren, Hui-Qin ; Zhao, Qing-Bo ; Wu, You-Liang ; Qiao, Zhuo-Yi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-9280762e74085d75e66443dffe5cfb1c0ea6d2da34a16febbaeb3647eb4030483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Blood Pressure</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Fluid Therapy - adverse effects</topic><topic>Fluid Therapy - methods</topic><topic>Heart Rate</topic><topic>Humans</topic><topic>Hypovolemia - etiology</topic><topic>Hypovolemia - physiopathology</topic><topic>Hypovolemia - therapy</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Resuscitation - adverse effects</topic><topic>Resuscitation - methods</topic><topic>Saline Solution, Hypertonic - adverse effects</topic><topic>Saline Solution, Hypertonic - chemistry</topic><topic>Saline Solution, Hypertonic - therapeutic use</topic><topic>Shock, Traumatic - complications</topic><topic>Shock, Traumatic - physiopathology</topic><topic>Shock, Traumatic - therapy</topic><topic>Tachycardia, Sinus - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Han, Juan</creatorcontrib><creatorcontrib>Ren, Hui-Qin</creatorcontrib><creatorcontrib>Zhao, Qing-Bo</creatorcontrib><creatorcontrib>Wu, You-Liang</creatorcontrib><creatorcontrib>Qiao, Zhuo-Yi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Shock (Augusta, Ga.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Han, Juan</au><au>Ren, Hui-Qin</au><au>Zhao, Qing-Bo</au><au>Wu, You-Liang</au><au>Qiao, Zhuo-Yi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of 3% and 7.5% Hypertonic Saline in Resuscitation After Traumatic Hypovolemic Shock</atitle><jtitle>Shock (Augusta, Ga.)</jtitle><addtitle>Shock</addtitle><date>2015-03</date><risdate>2015</risdate><volume>43</volume><issue>3</issue><spage>244</spage><epage>249</epage><pages>244-249</pages><issn>1073-2322</issn><eissn>1540-0514</eissn><abstract>Hypertonic saline solutions (HSSs) (7.5%) are useful in the resuscitation of patients with hypovolemic shock because they provide immediate intravascular volume expansion via the delivery of a small volume of fluid, improving cardiac function. However, the effects of using 3% HSS in hypovolemic shock resuscitation are not well known. This study was designed to compare the effects of and complications associated with 3% HSS, 7.5% HSS, and standard fluid in resuscitation. In total, 294 severe trauma patients were enrolled from December 2008 to February 2012 and subjected to a double-blind randomized clinical trial. Individual patients were treated with 3% HSS (250 mL), 7.5% HSS (250 mL), or lactated Ringer's solution (LRS) (250 mL). Mean arterial pressure, blood pressure, and heart rate were monitored and recorded before fluid infusion and at 10, 30, 45, and 60 min after infusion, and the incidence of complications and survival rate were analyzed. The results indicate that 3% and 7.5% HSSs rapidly restored mean arterial pressure and led to the requirement of an approximately 50% lower total fluid volume compared with the LRS group (P &lt; 0.001). However, a single bolus of 7.5% HSS resulted in an increase in heart rate (mean of 127 beats/min) at 10 min after the start of resuscitation. Higher rates of arrhythmia and hypernatremia were noted in the 7.5% HSS group, whereas higher risks of renal failure (P&lt; 0.001), coagulopathy (P &lt; 0.001), and pulmonary edema (P &lt; 0.001) were observed in the LRS group. Neither severe electrolyte disturbance nor anaphylaxis was observed in the HSS groups. It is notable that 3% HSS had similar effects on resuscitation because both the 7.5% HSS and LRS groups but resulted in a lower occurrence of complications. This study demonstrates the efficacy and safety of 3% HSS in the resuscitation of patients with hypovolemic shock.</abstract><cop>United States</cop><pmid>26091023</pmid><doi>10.1097/SHK.0000000000000303</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1073-2322
ispartof Shock (Augusta, Ga.), 2015-03, Vol.43 (3), p.244-249
issn 1073-2322
1540-0514
language eng
recordid cdi_proquest_miscellaneous_1690209851
source MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Adult
Blood Pressure
Double-Blind Method
Female
Fluid Therapy - adverse effects
Fluid Therapy - methods
Heart Rate
Humans
Hypovolemia - etiology
Hypovolemia - physiopathology
Hypovolemia - therapy
Kaplan-Meier Estimate
Male
Middle Aged
Resuscitation - adverse effects
Resuscitation - methods
Saline Solution, Hypertonic - adverse effects
Saline Solution, Hypertonic - chemistry
Saline Solution, Hypertonic - therapeutic use
Shock, Traumatic - complications
Shock, Traumatic - physiopathology
Shock, Traumatic - therapy
Tachycardia, Sinus - etiology
title Comparison of 3% and 7.5% Hypertonic Saline in Resuscitation After Traumatic Hypovolemic Shock
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A00%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%203%25%20and%207.5%25%20Hypertonic%20Saline%20in%20Resuscitation%20After%20Traumatic%20Hypovolemic%20Shock&rft.jtitle=Shock%20(Augusta,%20Ga.)&rft.au=Han,%20Juan&rft.date=2015-03&rft.volume=43&rft.issue=3&rft.spage=244&rft.epage=249&rft.pages=244-249&rft.issn=1073-2322&rft.eissn=1540-0514&rft_id=info:doi/10.1097/SHK.0000000000000303&rft_dat=%3Cproquest_cross%3E1690209851%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1690209851&rft_id=info:pmid/26091023&rfr_iscdi=true